CME Group Inc (NASDAQ:CME) was upgraded by JPMorgan Chase & Co. (NYSE:JPM)’s research analysts from an ‘underweight’ rating to a ‘neutral’ rating. Kenneth B. Worthington and team, however, don’t recommend CME Group Inc (NASDAQ:CME) at the current price, given the potential for volatility to stabilize and for volumes to normalize. CME Group Inc (NASDAQ:CME) is the world’s leading and most diverse derivatives marketplace offering the widest range of futures and options products for risk management. CME Group’s Volumes Surge JPMorgan Chase & Co. (NYSE:JPM) analysts feel CME Group Inc (NASDAQ:CME)’s leading interest rate futures business is witnessing surges in volume…
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
